CME Researcher Awarded NJ ACTS Grant to Advance In Vivo Testing of Biomaterial Implants

Dr. Roman Voronov, associate professor of Chemical and Materials Engineering at NJIT, has received a $50,000 research grant from the Tri-Institutional Clinical and Translational Research Pilot Program. The funded project, “Sterilization and In Vivo Testing of an Addressable Microfluidics Device for Commercial Applications,” aims to revolutionize how implanted biomaterials are evaluated prior to clinical trials.

In collaboration with Rutgers University's Animal Facility, Dr. Voronov’s lab will adapt its patented addressable microfluidic technology for in vivo use, enabling continuous, non-sacrificial monitoring of bone regeneration within living animals. This approach promises to improve the predictive accuracy of preclinical studies, reduce costs and minimize animal usage — marking a major advance in translational tissue engineering.